Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06850298 · ClinicalTrials.gov registry record · NA
H5N1 Milk Detection Study
A NA study of Influenza, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06850298: Recruiting NA study of Influenza, sponsored by Emory University.
NCT06850298 is a NA study of Influenza that is actively recruiting participants, run by Emory University. The registered enrollment target is 30 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06850298, a NA study of Influenza, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether drinking pasteurized milk (milk heated to kill harmful germs) that contains inactive particles of a flu virus called A(H5) could lead to the detection of the virus in the nose or throat. Inactive particles are not capable of causing disease. The results will help the Centers for Disease Control and Prevention (CDC) better understand how milk consumption could affect flu surveillance. Investigators also want to see if the body produces antibodies in response to this milk consumption.
Primary Outcome
Proportion of respiratory specimens (nasopharyngeal and combined nasal/oropharyngeal swabs) with detection of influenza after consumption of pasteurized milk contaminated with killed A(H5) virus
Conditions Studied
Interventions
- OTHER Pasteurized milk contaminated with killed A(H5) virus
Study Locations (1)
Georgia
- Hope Clinic - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-09 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT06850298 shows while recruiting
NCT06850298 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which Pasteurized milk contaminated with killed A(H5) virus is the first listed.
NCT06850298 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06850298 about?
NCT06850298 is a clinical study titled "H5N1 Milk Detection Study". The purpose of this study is to determine whether drinking pasteurized milk (milk heated to kill harmful germs) that contains inactive particles of a flu virus called A(H5) could lead to the detection of the virus in the nose or throat. Inactive particles are not capable of causing disease. The resu...
What is the current status of trial NCT06850298?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-05-09. Estimated completion is 2026-03.
What conditions does trial NCT06850298 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT06850298?
The interventions under investigation include: Pasteurized milk contaminated with killed A(H5) virus (OTHER).
Who is sponsoring clinical trial NCT06850298?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06850298 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06850298's enrollment target sits among peer trials
30 141st of 156 higher than 14 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
-
Exercise and COVID-19 Viral T-cell Immunity
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI